SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000628
Filing Date
2023-04-11
Accepted
2023-04-11 16:30:50
Documents
72
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rgrx-20221231x10k.htm   iXBRL 10-K 1760628
2 EX-23.1 rgrx-20221231xex23d1.htm EX-23.1 2731
3 EX-31.1 rgrx-20221231xex31d1.htm EX-31.1 10177
4 EX-32.1 rgrx-20221231xex32d1.htm EX-32.1 6345
5 EX-99.1 rgrx-20221231xex99d1.htm EX-99.1 12646
6 GRAPHIC rgrx-20221231xex99d1001.jpg GRAPHIC 8752
7 GRAPHIC rgrx-20221231xex99d1002.jpg GRAPHIC 8027
8 GRAPHIC rgrx-20221231xex99d1003.jpg GRAPHIC 8331
  Complete submission text file 0001410578-23-000628.txt   6620036

Data Files

Seq Description Document Type Size
9 EX-101.SCH rgrx-20221231.xsd EX-101.SCH 49412
10 EX-101.CAL rgrx-20221231_cal.xml EX-101.CAL 48648
11 EX-101.DEF rgrx-20221231_def.xml EX-101.DEF 139941
12 EX-101.LAB rgrx-20221231_lab.xml EX-101.LAB 357807
13 EX-101.PRE rgrx-20221231_pre.xml EX-101.PRE 304211
66 EXTRACTED XBRL INSTANCE DOCUMENT rgrx-20221231x10k_htm.xml XML 1038247
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 23813714
SIC: 2834 Pharmaceutical Preparations